Last updated: 2026-09-28 12:59:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
DataMeds AI, Inc. (MEDS) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NASDAQ. The stock is currently priced at $3.97, with a market capitalization of $9.94M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.82 to $12.31. This page covers its latest market performance, valuation, price trends and company information.
$9.94M | |
$3.11 | |
$504.00 | |
$0.82 | |
$3.11 | |
12.58M | |
6.36M | |
-- | |
$12.31 | |
$0.82 | |
-- | |
-- |
DataMeds AI, Inc. (MEDS) is trading at $3.97 in pre-market trading as of 2026-09-28 12:57:00, up 27.78% ($0.86) from the previous close of $3.11
Pre-market trading shows how investors are pricing MEDS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, DataMeds AI, Inc. (MEDS) moved from $4.64 to $3.97, representing a decline of 14.35% ($0.67).
The stock traded between $2.99 and $6.75 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 4.12 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 27.4%
MEDS is currently trading at $3.97, placing it 27.4% of the way from its 52-week low of $0.82 to its 52-week high of $12.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of DataMeds AI, Inc. (MEDS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.